18.01.2020 10:42

Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

Verboon et al., J Neurol Neurosurg Psychiatry. 2020

Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA; IGOS Consortium.

Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):113-121. doi: 10.1136/jnnp-2019-321496. Epub 2019 Oct 5. PubMed ID: 31586949

 

Further Information:

PubMed

Hans-Peter Hartung
 

Verantwortlich für den Inhalt: E-Mail sendenNeuroscience Network Düsseldorf